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Abstract
The cellular prion protein, a major player in the neuropathology of prion dis-
eases, is believed to control both death and survival pathways in central neurons. 
However, the cellular and molecular mechanisms underlying these functions remain 
to be deciphered. This chapter presents cytopathological studies of the neurotoxic 
effects of infectious prions and cellular prion protein-deficiency on cerebellar 
neurons in wild-type and transgenic mice. The immunochemical and electron 
microscopy data collected in situ and ex vivo in cultured organotypic cerebel-
lar slices indicate that an interplay between apoptotic and autophagic pathways 
is involved in neuronal death induced either by the infectious prions or by prion 
protein-deficiency.
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1. Introduction
1.1 Prion diseases
Transmissible spongiform encephalopathies (TSEs) or “prion diseases” are 
fatal neurodegenerative disorders in humans (Creutzfeldt-Jakob disease (CJD), 
Gerstmann-Straüssler-Scheinker syndrome (GSS), variant CJD (vCJD), fatal famil-
ial insomnia (FFI) and kuru) and in animals (bovine spongiform encephalopathy 
(BSE), transmissible mink encephalopathy (TME), chronic wasting disease of 
cervids (CWD), camel prion disease (CPD), and scrapie of sheep and goats) [1–4]. 
Prevailing over a viral etiology, the conformational corruption of host-encoded cel-
lular prion protein (PrPc) by a pathogenic isoform (PrPTSE) is now widely accepted 
as underlying prion transmission and pathogenesis in TSEs [5–7].
1.2 PrPc functions
Prnp-knockout mice were generated in order to investigate the physiologi-
cal functions of PrPc. In either mixed C57BL/6 j x129/Sv(ev) (Zurich I, ZrchI, 
PrnpZH1/ZH1, [8]) or pure 129/Ola (Npu, Edinburgh, Edbg, [9]) or C57BL/6J 
(Zurich III, ZrchIII, PrnpZH3/ZH3, [10]) genetic backgrounds, the first Prnp null 
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mouse strains produced were viable with no clear abnormality except for their 
resistance to prion infection [11] and absence of obvious neurodegeneration. 
Similar absence of neurodegeneration or histopathology resulted from deple-
tion of neuronal PrPc in adult conditional Prnp-knockout NFH-Cre/tg37 mice 
[12]. Thus, a physiological function of PrPc that is essential for life seemed to be 
ruled out unless it is highly redundant or is compensated. Nevertheless, looking 
at different neuronal and other cell functions in PrPc-ablated mice has revealed a 
number of differences that can be attributed to the physiological functions of PrPc 
(see [13] for review).
PrPc has been implicated in neurotransmission, olfaction, proliferation and 
differentiation of neural precursor cells, neuritic growth, neuronal homeostasis, cell 
signaling, cell adhesion, myelin maintenance, copper and zinc transport, as well as 
neuroprotection against toxic insults, such as oxidative stress and excitotoxicity (see 
[14, 15] for reviews). Increasing evidence links prion protein misfolding and accu-
mulation to neurodegeneration in prion diseases. Accordingly, several nonexclusive 
mechanisms of prion-mediated neurotoxicity are currently under investigation (see 
[16] for review). PrPc has been localized in three major sites: enriched in lipid rafts, 
anchored in the outer plasma membrane leaflet by its GPI tail [17], and intracellularly 
in the Golgi apparatus early and late endosomes [18, 19]. Since lipid rafts are pivotal 
microdomains for signal transduction, PrPc is likely triggering intracellular signaling 
pathways [20, 21]. The first evidence that PrPc might mediate extracellular signals 
was the caveolin-1-dependent coupling of PrPc to the tyrosine-protein kinase Fyn 
[21]. From this pioneering work, accumulating data suggested that PrPc functions as 
a “dynamic cell surface platform for the assembly of signaling molecules,” partnering 
with other membrane proteins to transduce cellular signaling [22].
1.3 Synaptic PrPc
Whereas, PrPc is highly expressed in both neurons and glial cells of the CNS 
[19, 23, 24], it is preferentially localized in the pre- and postsynaptic terminals of 
neurons [19, 24, 25]. Immunocytochemical studies of primate and rodent brains 
[25, 26] including an EGFP-tagged PrPc in transgenic mice, showed that PrPc is 
enriched along axons and presynaptic terminals [27–29], and undergoes anterograde 
and retrograde transport [30, 31]. Such a synaptic targeting of PrPc suggests that it 
could be involved in preserving synaptic structure and function. Indeed, synaptic 
dysfunction and loss are early prominent events in prion diseases [32, 33]. However, 
a functional role of PrPc at synapses is not consistently supported by functional data 
and still remains contentious.
Insights into possible mechanisms by which PrPc modulates synaptic mecha-
nisms and neuronal excitability at a molecular level have been provided by the 
documented interactions of PrPc with several ion channels including the voltage-
gated calcium channels (VGCCs) [34], the N-methyl-D-aspartate glutamate 
receptors (NMDARs) [35] and the voltage-gated potassium channels Kv4.2 [36]. 
PrPc has been shown to regulate NMDARs due to its affinity for copper that leads 
to inhibition of glutamate receptors and excitotoxicity [37, 38]. While interac-
tion of PrPc with these channels may account for some of its functions, a toxic 
response can also be activated when PrPc misfolds. A structural change in cell 
surface PrPc has been proposed to simultaneously disrupt NMDAR function and 
plasma membrane permeability, leading to dysregulation of ion homeostasis and 
neuronal death [39, 40]. PrPc can also interact with kainate receptor subunits 
GluR6/7 [41], α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
receptors subunits GluA1 and GluA2 [42, 43], and metabotropic glutamate 
receptors of group 1 mGluR1 and mGluR5 [44, 45]. PrPc can interact with the 
β-amyloid peptide (Aβ) and the later [45, 46] is believed to underlie the Aβ 
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oligomer-induced disruption of LTP in Alzheimer’s disease [47]. Thus, PrPc seems 
to behave as a cell surface receptor for synaptic oligomers of the Aβ peptide and, 
of other β-sheet-rich neurotoxic proteins [40].
1.4 PrPTSE-related neurotoxicity in prion diseases
The histopathological signature of TSEs notably relies on the aggregation of 
PrPTSE, vacuolation of the brain tissue, astrogliosis, and synaptic and neuronal loss. 
How neurons, the major targets of prions, die, remains a central question in prion 
diseases. The absence of neurodegenerative phenotypes after depletion of PrPc 
suggests that neurotoxicity is not due to a loss of PrPc function but rather results 
from a gain of toxicity upon its conversion to PrPTSE, which then acts on the central 
nervous system (CNS) [48]. Although PrPc is required for propagation of infectious 
prions and PrPTSE-mediated toxicity [49], the mechanisms by which prions are lethal 
for neurons remain mostly unknown. Nevertheless, the endogenous PrPc conversion 
has been shown to cause neuronal dysfunction and death, rather than PrPTSE itself 
which does not seem to be directly neurotoxic. A precise understanding of the factors 
leading to neurotoxicity in prion infections is crucial to developing targeted therapies 
and investigating the role of PrPc in neurons should provide insight.
The conformational conversion of PrPc begins on the neuronal surface, where 
PrPc interacts with exogenous PrPTSE, and then proceeds within endogenous 
compartments suggesting that neurotoxicity may be triggered by PrPc misfold-
ing both at the cell surface and inside the cell. In both acquired and genetic prion 
diseases, intracellular PrPc misfolding would ultimately alter synaptic proteostasis, 
either through an indirect unfolded protein response (UPR)-mediated mecha-
nism [50], likely arising either from an impairment of the neuronal ubiquitin-
proteasome system (UPS) [51], or a direct interference with secretory trafficking 
of PrPc-interacting cargoes [52]. Common features associated with prion infections 
include Ca2+ dysregulation, release of reactive oxygen species, and induction 
of endoplasmic-reticulum (ER) stress, which has been recently suggested as an 
important player in pathogenesis [53]. Prion-infected mice show brisk activation 
of the UPR and specifically of the PERK pathway, resulting in eIF2α phosphoryla-
tion and suppression of translational initiation. PERK inhibition protects mice 
from prion neurotoxicity, confirming an important pathogenic role of ER stress 
[50]. Since UPR activation and/or increased eIF2α-P levels as well as UPS impair-
ment are commonly seen in prion disorders and in Alzheimer’s and Parkinson’s 
diseases, translational control, and UPS stimulation strategies may offer a common 
therapeutic opportunity to prevent synaptic failure and neuronal loss in protein 
misfolding diseases [51, 54].
1.5 Loss of PrPc anti-inflammatory protective function in prion disease
A protective role of PrPc against a noxious insult mediated by the pro-inflamma-
tory cytokine tumor necrosis factor-α (TNFα) has recently been demonstrated [55]. 
The α-secretase activity mediated by the TNFα-converting enzyme (TACE) was 
impaired at the surface of Fukuoka and 22L scrapie prion-infected neurons. 
Furthermore, the activity of 3-phosphoinositide-dependent kinase-1 (PDK1) which 
inactivates phosphorylation and caveolin-1-mediated internalization of TACE is 
increased in scrapie-infected neurons. PDK1 was shown to be controlled by RhoA-
associated coiled-coil containing kinases (ROCK) which favored the PrPTSE produc-
tion. In these neurons, exacerbated ROCK activity overstimulated PDK1 activity 
which canceled the neuroprotective α-cleavage of PrPc by TACE α-secretase, 
physiologically precluding PrPTSE production. Inhibition of ROCK lowered PrPTSE 
in prion-infected cells as well as in the brain of prion-diseased mice which had 
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extended lifespans [56]. Indeed, the dysregulation of TACE resulted in PrPTSE 
accumulation and reduced the shedding of TNFα receptor type 1 (TNFR1) from the 
neuronal plasma membrane. Inversely, inhibition of PDK1 in vitro promoted TACE 
localization at the plasma membrane, restoring TACE-dependent α-secretase activ-
ity and shedding of PrPc and TNFR1, thereby attenuating PrPTSE-induced neurotox-
icity. Similarly, inhibition or siRNA-mediated silencing of PDK1 extended survival 
and reduced motor impairment of scrapie-diseased mice [55]. Mechanistically, PrPc 
coupling to the NADPH oxidase-TACE α-secretase signaling pathway limits the sen-
sitivity of recipient cells to TNFα by promoting TACE-mediated cleavage of TNFα 
receptors (TNFRs) and the release of soluble TNFRs. PrPc expression was further 
shown to be necessary for maintaining TACE α-secretase at the plasma membrane 
and its TNFR shedding activity. The loss of PrPc provoked TACE internalization, 
canceling TACE-mediated cleavage of TNFR. This rendered PrPc-depleted cells and 
Prnp-knockout mice highly vulnerable to pro-inflammatory TNFα insult. Thus, 
abnormal trafficking and activity of TACE in prion diseases likely originates from a 
loss of PrPc cytoprotective function [57].
Synaptolysis is believed to initiate the neurodegeneration arising after a decrease 
in depolarization-induced calcium transients that progressively impairs glutamate 
release [34]. However, although cytoskeletal disruption in dendritic spines plays a 
major role in neuronal dysfunction, neither changes in postsynaptic densities and 
presynaptic compartment nor disruption of afferent innervation have been system-
atically observed, suggesting that even at terminal stages of the disease neuronal 
loss may not result from deafferentation as previously proposed in the hippocampus 
and cerebellum of scrapie-infected mice [33, 58, 59]. Thus, neuronal vulnerability 
to pathological protein misfolding appears to be more strongly dependent than 
previously thought, on the structure and function of target neurons.
Recent investigations of scrapie pathogenesis in the mouse cerebellum revealed 
an early upregulation of tumor necrosis factor-α receptor type 1 (TNFR1), a key 
mediator of neuroinflammation at the membrane of astrocytes enveloping Purkinje 
cell (PC) excitatory synapses already at the preclinical stage of the disease before 
PrP22L precipitation, GFAP astrogliosis, and PC death [59]. The contribution of 
perisynaptic astrocytes to prion pathogenesis through TNFR1 upregulation remains 
to be clarified and, although the cell types responsible for PrP22L production in the 
cerebellum are still uncertain, these data suggest a critical role for astrocytes in 
prion pathogenesis.
2. Mechanisms of neuronal death in prion diseases
Despite the overall advances made in this field during the last decades, the 
sequence of cellular and molecular events leading to neuronal cell demise in TSEs 
remains obscure. At present, neuronal cell death can be envisioned as resulting 
from several parallel, interacting, or sequential pathways involving protein process-
ing and proteasome dysfunction [60], oxidative stress [61], inflammation [55] 
apoptosis, and autophagy [62]. The repertoire of pathways that lead to neuronal 
death is however limited [63]. In TSEs, apoptosis is the most popular theory of cell 
death but is not convincingly documented. In all cases, the probable disruption of 
both neuronal metabolism and circuits generates a pro-apoptotic signal for neurons. 
In addition to disruption of cellular proteostasis, UPS dysfunction may lead to 
neurotoxicity by activating pro-apoptotic pathways. PrPTSE aggresomes can associ-
ate with pro-apoptotic factors such as vimentin and caspases [60]. On the other 
hand, autophagy has been reported in TSEs, but its role in prion disease pathology 
is not well established [64]. However, the extensive synaptic autophagy observed 
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in prion diseases [65] has been proposed to contribute to overall synaptic degenera-
tion, a major precocious pathological feature leading to neuronal death in TSEs. 
This chapter reports recent biochemical and cytopathological studies investigating 
the involvement of apoptosis and autophagy in neuronal loss induced by infectious 
prions as well as by PrPc-deficiency in the mouse cerebellum.
Among TSEs, scrapie is a natural ovine prion disease widely studied in mouse 
models using murine-adapted prion strains (22L, ME7) that, akin to natural prion 
strains, differ in their rate of disease progression (i.e., duration of the incubation 
period), as well as the extent and regional pattern of brain histopathology [66, 67]. 
For example, the characteristic of a prion strain mostly relies on specific biochemical 
properties related to PrPTSE misfolding. The variable susceptibility of neuronal types to 
prion infection also emerges as another critical parameter that underlies the complex 
mechanisms of prion pathogenesis [54, 68, 69] and affects PrPTSE progression along 
defined anatomical routes [70]. The cellular and molecular mechanisms involved in 
targeting PrPTSE to specific neuronal populations [33, 71, 72] and neuron-to-neuron 
spreading of prions in the CNS remain elusive [73].
In several prion diseases, the cerebellum is a preferential prion target for scrapie 
[74–78], also observed in Creutzfeldt-Jakob disease (CJD) cases [79–87]. Cerebellar 
circuits are exquisitely patterned and the expression patterns of zebrins in PCs define 
a topographical map of genetically determined zones controlling sensory-motor 
behavior [88, 89]. Subsets of PCs expressing zebrins alternate with subsets of zebrin-
free PCs, thus forming complementary stripes of biochemically distinct PCs [88]. The 
most comprehensively studied zonal marker is zebrin II/aldolase C (ZII/AldC) [90]. 
The expression of ZII/AldC by itself, however, is not sufficient to recapitulate the full 
complexity of the cerebellar cortex because of the many other PC subtypes [91, 92].
In a recent study [59], the parasagittal compartmentation of the cerebellar 
cortex restricted 22L scrapie pathogenesis, including PrP22L accumulation, PC 
neurodegeneration, and gliosis. Indeed, PCs displayed a differential, subtype-
specific vulnerability to 22L prions with zebrin-expressing PCs being more resistant 
to prion toxicity, whereas in stripes where PrP22L accumulated most zebrin-deficient 
PCs were lost and spongiosis was accentuated (Figure 1). Although this banding 
pattern of PrP22L accumulation is most likely delineated by structural constraints 
of compartmentation, different biochemical properties of PC subpopulations may 
well determine their differential resistance to scrapie prions.
2.1 Prion-induced apoptosis
2.1.1 Apoptotic pathways in prion-infected neurons
The mechanism of prion neurotoxicity requires neuronal expression of PrPc 
and is based on the subversion of its normal function triggered by an interaction 
with PrPTSE at the cell surface, thereby transducing a toxic signal into the cell. 
Nevertheless, this has been challenged by the discovery of a monomeric, highly 
α-helical form of PrPc with strong in vitro and in vivo neurotoxicity that elicits 
autophagy and apoptosis with a molecular signature similar to that observed in 
prion-infected animal brains [93]. This toxic PrP (TPrP) killed PrP-deficient 
neurons in vitro suggesting that a PrP-derived toxic signal can be generated within 
neurons independently of endogenous membrane-bound PrPc. Indeed, postnatal 
ablation of PrPc expression in neurons reversed neurodegeneration and affected 
disease progression in mice even though glial replication was maintained and PrPTSE 
accumulated [94]. Thus, prion pathogenesis is governed by both cell-autonomous 
mechanisms responsible for cellular dysfunction and neurodegeneration and 
noncellular-autonomous mechanisms propagating prion spread [95].
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Endoplasmic-reticulum stress has recently been implicated in an apoptotic 
regulatory pathway activated by changes in Ca2+ homeostasis or accumulation of 
aggregated proteins. In both these situations, Ca2+ is released and caspase-12 is 
activated [96]. ER stress and caspase-12 activation have been identified in prion-
infected N2a cells as well as in the brains of prion-diseased mice and CJD patients 
[97]. The synaptic dysfunction and neuronal death caused by PrPTSE accumulation 
via dysregulation of the Ca2+-sensitive phosphatase calcineurin (CaN) provides 
further evidence of the role of ER stress and Ca2+ homeostasis in prion-induced 
neurodegeneration [98]. The increase in Ca2+ cytosolic levels following hyperac-
tivation of CaN dysregulates the pro-apoptotic Bcl-2-associated death promoter 
(Bad), and the transcription factor cAMP response element-binding (CREB). 
Dephosphorylated Bad interacts with Bax causing mitochondrial stress and apopto-
sis while dephosphorylated CREB cannot translocate into the nucleus to regulate the 
transcription of synaptic proteins, resulting in synaptic loss [99].
2.1.2 Mitochondrial apoptosis in prion-infected cerebellar neurons
PrPc has recently been suggested to participate in anti-apoptotic and anti-
oxidative processes by interacting with the stress inducible protein 1 (STI-1) to 
regulate superoxide dismutase (SOD) activation [100]. The PrPc octapeptide repeat 
Figure 1. 
Banding pattern of PrP22L, EAAT4 zebrin and PC loss in the EAAT4-eGFP mouse cerebellum A–H. The 
pattern of PrP22L deposits (immunoperoxidase (immunoHRP) in A and E is artificially visualized in red in C 
and G) correlated with the banding pattern of the zebrin excitatory amino acid transporter 4 (EAAT4-eGFP, 
green in B, F) in merged PrP22L-EAAT4 images C and G in the cerebellar vermis (A–C) and hemispheres 
(E–G) infected with 22L ic. (clinical stage 145 dpi). D, H. EAAT4-eGFP PCs in the same regions of the vermis 
(D) and hemisphere (H) of a noninfected EAAT4-eGFP mouse as shown in the cerebellum of the 22L-infected 
EAAT4-eGFP mouse (A–G). The zebrin bands are numbered according to the current nomenclature in 
A–K and indicated by arrowheads in F. I–K. In the cerebellum infected icb. (preclinical stage), two bands of 
PrP22L deposits (6 and 7) are visualized by immunoHRP in I and artificially visualized in green in K. These 
cross crus2 and paramedian lobule (PM) and display a marked loss of CaBP-immunofluorescent PCs (red). 
Scale bars = 50 μm. L. Quantitative analysis of EAAT4-expressing and -nonexpressing PCs in the cerebellum 
of EAAT4-eGFP mice infected i.c. (clinical stage). The EAAT4-nonexpressing PCs are more sensitive to 22L 
toxicity. *p < 0.05. The number of mice analyzed is indicated on the bars in the graph.
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region contains a B-cell-lymphoma 2 (Bcl-2) homology domain 2 (BH2) of the 
family of apoptosis regulating Bcl-2 proteins involved in the anti-apoptotic function 
of Bcl-2. A direct interaction between PrPc and the C-terminus of anti-apoptotic 
Bcl-2 has also been found [101, 102]. In addition, the third helix of PrPc impaired 
the BAX conformation changes required for apoptosis activation suggesting that 
PrPc may assure the neuroprotective function of Bcl-2 [103]. Along this line, Prnp0/0 
neurons were more susceptible to apoptotic stimuli such as serum deprivation than 
their wild-type counterparts, whereas they were rescued by PrPc or Bcl-2 expression 
[104, 105]. PrPc also protected primary neurons against BAX-dependent apoptosis. 
Furthermore, transgenic expression of Bax or Bax and Prnp indicated that Prnp 
impairs Bax-dependent neuronal death [106].
Activation of the mitochondrial apoptotic pathway was observed when pri-
mary neurons were exposed to aggregated neurotoxic peptides like PrP106-126 or 
recombinant mutant PrP [107–109]. Apoptotic neuronal death demonstrated by 
activation of several caspases and DNA fragmentation is evident in natural prion 
diseases as well as in experimental models of TSEs [76, 110, 111]. In the cerebellum, 
apoptotic features have been observed in granule cells in CJD patients [112, 113] 
as well as in mice experimentally infected with CJD [111] and scrapie strains 301V, 
87V, 22A [76], 79A [110], M1000/Fukuoka-1 [114], 127S [115], 22L, 139A, and RML 
[116, 117]. More recently, activation of caspase-3 was found in PCs of 22L-infected 
mice [59]. However, cerebral upregulation of the pro-apoptotic factor BAX has been 
reported in some cases of scrapie-infected rodents [116, 118], whereas no changes in 
clinical illness and neuropathology could be detected in the brain of Bax-deficient 
mice infected with 6PB1 mouse-adapted BSE prions [119]. This suggested that 
BAX-mediated cell death is not involved in the pathological mechanism induced by 
BSE. Nevertheless, BAX is known to be involved in neuronal death in Tg(PG14) [120] 
and Ngsk PrnP0/0 [121] murine models of PrP-deficiency-linked diseases. In these 
cases, neuronal death is restricted to cerebellar neurons that are known to undergo 
BAX and BCL2-dependent apoptosis in other abnormal conditions [122, 123]. This 
led us to further investigate the involvement of intrinsic mitochondrial apoptotic 
pathways in a cerebellotropic prion disease such as the 22L scrapie. For this purpose, 
the pathogenesis of 22L scrapie in the brain of Bax-KO (Bax−/−) mice [124] and in 
mice expressing a human Bcl-2 transgene [125] was analyzed. Clinical signs of 22L 
scrapie (mainly ataxia) were similar to those previously described for C57Bl/6 mice 
[126]. Bax−/− and HuBcl-2 mice infected by either intraperitoneal (ip.) or intracer-
ebellar (icb.) route displayed ataxia 10–15 days sooner than wild-type mice. Survival 
times however, were similar in all genotypes (i.e., 223 dpi ip. and 129 dpi icb.). 
whereas 22L induced more severe cerebellar spongiosis via the icb. route than the ip. 
route, similar lesion profiles [71] were induced by 22L ip. in the brain of Bax−/− and 
wild-type mice and lesion profiles were not different in the brain of Bax−/−, HuBcl-2 
and wild-type mice infected with 22L icb. (Figure 2). Anatomopathological analysis 
of the cerebral and cerebellar cortices of the 22L-diseased Bax−/− and HuBcl-2 mice 
did not reveal any modified patterns of vacuolation, astrogliosis, and PrP22L deposits 
irrespective of the inoculation route. Synaptophysin and calcium-binding protein 
(CaBP) immunohistochemistry also revealed severe synapse and PC loss in all cases 
(Figure 3). Finally, quantitative analysis of the cerebellar granule cells immuno-
labeled for the nuclear marker NeuN revealed a significant loss of neurons in all 
genotypes infected by the icb. route (Figure 4). Surprisingly, no significant differ-
ence could be detected between Bax−/− and wild-type mice infected by the icb. route, 
whereas HuBcl-2 mice whose granule cells are rescued from developmental cell 
death [127] lost more granule cells than wild-type and Bax−/− mice (Figure 4). These 
data indicate that neither suppression of Bax nor overexpression of Bcl-2 protected 
cerebellar neurons from 22L scrapie-induced neurotoxicity. Thus, the granule cell 
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and PC death induced by 22L scrapie does not seem to involve BAX and cannot be 
counteracted by overexpression of the anti-apoptotic factor BCL-2. However, cleaved 
caspase-3 and -9 were observed in the brains of Bax−/− mice, suggesting that apop-
tosis may occur through (an) alternative mechanism(s) in TSEs of infectious origin. 
Indeed, apoptotic features have been reported in the brain of wild-type mice infected 
with RML, in the absence of Bax upregulation [116], while other proteins involved 
in cell death including those associated with the mitochondrial inner membrane, 
the UPS and the endoplasmic-reticulum-associated protein degradation (ERAD) 
pathway [128] were upregulated.
2.1.3 Prion-induced neuronal death in cerebellar organotypic slice cultures (COCS)
In the recently developed prion cerebellar organotypic slice culture (COCS) 
assay, progressive spongiform neurodegeneration that closely reproduce features of 
prion disease can be induced ex vivo [117, 129]. Infecting COCS with three different 
scrapie strains (RML, 22L, 139A) produced three distinct patterns of prion protein 
Figure 2. 
Spongiosis lesion profiles in the brain of wild-type (WT), Bax−/− and HuBcl-2 mice infected ip. and icb. with 
the 22L scrapie prion strain. A. Very similar lesion profiles were induced by 22L scrapie ip. in Bax−/− and WT 
mice. 22L induced more severe cerebellar spongiosis via the icb. route than via the ip. route. 1: cingulate and 2nd 
motor cortices, 2: lateral and medial septum, 3: caudate putamen, 4: retrosplenial cortex, 5: hippocampus, 6: 
thalamus, 7: hypothalamus, 8: superior colliculus, 9A: cerebellar molecular layer, 9B: cerebellar granular layer, 
9C: cerebellar white matter, 10: medulla. B. Very similar lesion profiles were induced by 22L scrapie icb. in 
Bax−/−, HuBcl-2 and WT mice.
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deposition accompanied by salient features of prion disease pathogenesis such as 
severe neuronal loss, a pro-inflammatory response, and typical neuropathological 
changes (spongiform vacuolation, tubulovesicular structures, neuronal dystrophy, 
Figure 3. 
Anatomopathology of 22L scrapie ip. and icb. in the cerebellum of WT, Bax−/− and HuBcl-2 mice. Neither 
Bax knockout nor HuBcl-2 overexpression modified vacuolation (Mason’s trichrome), astrogliosis (GFAP 
immunoHRP) and PrP22L accumulation (PrP immunoHRP) patterns in the cerebellar cortex of the 22L ip. and 
icb. infected Bax−/− and HuBcl-2 mice compared to the WT mice. Synaptophysin and CaBP reveal respectively 
synapse and PC loss in the cerebellum of all mice. Loss of Neun-immunostained GCs is also prominent in the 
cerebellum of the WT, Bax−/− and HuBcl-2 infected icb., yet seemed less pronounced in the mice infected ip.
Figure 4. 
Quantitative analysis of cerebellar GCs immunostained for the nuclear marker NeuN revealed a significant 
loss of neurons in all genotypes infected icb., but not ip. *p < 0.05; **p < 0.01. Whereas Bax−/− and WT mice lost 
a similar amount of GCs, the HuBcl-2 mice lost more GCs than the WT and Bax−/− mice. NIB, noninfected 
brain homogenate.
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and gliosis). Neurodegeneration did not occur when PrP was genetically removed 
from neurons and was abrogated by compounds known to antagonize prion replica-
tion. Also, calpain inhibitors, but not caspase inhibitors, prevented neurotoxicity 
and fodrin cleavage; whereas, prion replication was unimpeded indicating that 
inhibiting calpain uncouples prion replication and neurotoxicity. These data 
validate the COCS as a powerful model system that faithfully reproduces many 
morphological hallmarks of prion infections and shows that prion neurotoxicity in 
cerebellar granule cells is calpain-dependent but caspase-independent.
Furthermore, significant spine loss and altered dendritic morphology, analogous 
to that seen in vivo were induced by RML scrapie in COCS [130], while the deposi-
tion pattern and subcellular distribution of PrP22L (i.e., granular deposits associated 
with neurons, astrocytes, and microglia but not PCs in the neuropil of the PC and 
molecular layers [131]), closely resembled that observed in vivo [59].
Following infection of COCS from C57Bl6/J, ZH-I Prnp0/0, and Tga20 PrP-over-
expressing mice with brain homogenate from C57Bl6/J infected intracerebrally 
(ic.) with either 22L or 139A scrapie prions, PrP22L and PrP139A accumulation could 
be detected on histoblots from wild-type and Tga20 COCS, respectively, 30 and 
20 days post infection (dpi), but not on histoblots from ZH-I mice (Figure 5). 
Furthermore, quantitative analysis of PCs in these COCs indicated that a severe loss 
of neurons was induced by 22L prions in wild-type slices at 30 dpi (22 ± 2 surviving 
PCs/slice) and in Tga20 slices at 20 dpi (293 ± 68 surviving PCs) as well as by 139A 
prions in wild-type slices at 30 dpi (145 ± 63 surviving PCs/slice) and in Tga20 slices 
at 20 dpi (191 ± 31 surviving PCs/slice) compared to noninfected control COCS 
(220 ± 27 surviving PCs/slice in wild-type slices and 357 ± 71 surviving PCs/slice 
in Tga20 slices) (Figure 6). At 30 dpi, the trilaminar organization of the cerebellar 
cortex was evident in noninfected COCs, which did not exhibit any clear ultrastruc-
tural modifications (Figure 7). Nevertheless, numerous vacuoles, autophagosomes, 
and lysosomes had formed in granule cells infected by 22L and 139A (Figure 8). 
In diseased PCs, autophagosomes with double membranes and rough endoplasmic 
reticulum (Nissl bodies) formed compartmented organelles of various sizes (1–10 
compartments) resembling different stages leading to multivesicular vacuoles 
(Figure 9). Although further investigations are necessary, these ultrastructural 
Figure 5. 
Histoblots of cultured organotypic cerebellar slices (COCS) infected with the 22L and 139A scrapie strains. PrPc 
was detected in histoblots of noninfected (sham) COCS from WT C57Bl6/J (A) and Tga20 PrP-overexpressing 
(C), but not PrP-deficient ZH-I PrnP0/0 (B) mice. PrPc was completely digested by proteinase K (PK) in these 
COCS. After 30 and 20 days postinfection (dpi), PK revealed undigested PrP22L and PrP139A respectively in the 
WT and Tga20, but not ZH-I Prnp0/0 infected COCS.
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Figure 6. 
Mean numbers of CaBP-immunofluorescent PCs in WT and Tga20 COCS noninfected (sham) and infected 
with 22L and 139A scrapie prions at 30 dpi.
Figure 7. 
Ultrastructural features of the C57Bl6/J mouse cerebellar cortex in noninfected COCS after 30 DIV. A. Laminar 
organization of the cerebellar cortex with PC at the interface between internal granular layer (IGL) and 
molecular layer (ML). B. Granule cells in the IGL. C. IGL neuropil. D. PC dendrite (d) in the ML neuropil. 
E, F. Asymmetrical synapses (arrows) on interneurons dendrites (E) and PC spines (F). G. PC. N, PC 
nucleus. H. A smooth saccule (arrow) typically separates a mitochondrion from the plasma membrane in 
the PC neuroplasm. I. Nissl body in the PC neuroplasm. J. Degenerated cell with electron-dense vacuolated 
cytoplasm. K. Autophagic digestion of a mitochondrion (*). L. Autophagic profiles in a PC axon (*). Scale 
bars = 10 μm in A, 2 μm in B–D, G, J, 500 nm in E, F, H, I, K, L.
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Figure 8. 
Cytopathology of the C57Bl6/J mouse cerebellar cortex in COCS infected with 22L (A–F) and 139A (G–L) 
scrapie prions at 30 dpi. A. IGL. B–D. Autophagic profiles in the IGL neuropil. B. Magnification of the inset 
in A. D. Electron-dense lysosomes. E, F. Various stages of ER-derived reticulated organelles (arrows) in the 
neuroplasm of a PC. G. Neurodegenerating profiles (*) in the IGL neuropil. H, I. PC neuroplasm containing 
different stages of ER-derived reticulated organelles (arrows) and vacuoles. Scale bars = 2 μm in A–D, G–I, 
500 nm in E, F.
alterations were not observed in noninfected slices suggesting that a specific effect 
of prions links prion-induced ER stress to this morphological ER modification.
2.2 Prion-induced autophagy
Autophagy and apoptosis are activated in many neurodegenerative diseases 
featured by ubiquitinated misfolded proteins. In neurons, the degradation of 
abnormal proteins such as α-synuclein in Parkinson’s disease, β-amyloid peptide in 
Alzheimer’s disease (AD), or PrP in TSEs occurs by autophagy [14, 132–135]. These 
cardinal proteins contribute to synaptic dysregulation and altered organelles lead-
ing to apoptosis. The neurodegenerating neurons exhibit robust accumulation of 
cytosolic autophagosomes (see [14] for review, Figure 10) suggesting a dysregulation 
of the autophagic flux resulting from autophagic stress, due to an imbalance between 
protein synthesis and degradation [136]. Autophagy reduces intraneuronal aggre-
gates and slows down the progression of clinical disease in experimental models of 
AD [137–139] and prion diseases [140, 141]. Thus, dysregulation of the autophagic 
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flux impairs the elimination of misfolded proteins and damaged organelles which 
then accumulate in the cytoplasm and contribute to cell dysfunction and death [142].
Together, spongiform vacuolation of the neuropil, synaptolysis, accompanied 
by neuronal cell loss and gliosis constitute the classical neuropathological quartet 
of TSEs. The typical “spongiform vacuoles” are believed to result from autophagy 
and develop within neuronal elements, myelinated axons, and myelin sheaths 
Figure 9. 
Cytopathological formation and evolution of ER-derived profiles in PCs of COCS infected with 139A 
scrapie prions at 30 dpi. A, B. Reticulation and sequestration of neuroplasm by ER saccules forming small 
double-membrane vesicles (arrows) containing ribosome-like particles (arrowheads in B) on both external 
and internal faces. ER, endoplasmic reticulum. C, D. Large compartmented ER-derived organelles which 
still display membrane-bound ribosomes (arrowheads). C. High magnification of Figure 8H. D. See the 
enlargement between membranes (*). E. Fusion (arrows) of small ER-derived double-membraned vacuoles 
with lysosomes (L). F. Large ER-derived double-membraned vacuoles with enlarged intermembrane space (*) 
transforming into multivesicular vacuoles (arrows). Scale bars = 500 nm.
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[143, 144]. Autophagic vacuoles are increased in prion-diseased neurons [64, 65, 
145], and the scrapie responsive gene 1 (SRG1) protein is overexpressed and bound 
to neuronal autophagosomes in the brain of scrapie- and BSE-infected animals and 
CJD-diseased humans [146, 147]. In addition, LC3-II, a marker of autophagosomes 
is increased in the cytosol of neurons in scrapie-infected hamsters and CJD- and 
FFI-diseased patients.
Recent evidence indicated that PrPc, but not truncated PrP devoid of the 
N-terminal octapeptide repeat region, exerts a negative control on the induc-
tion of autophagy [148]. Thus, the loss or subversion of PrPc function resulting 
from prion infection may upregulate autophagy in diseased neurons [16]. While 
Figure 10. 
Autophagy in PCs of 4.5 (A–E) and 12 (F) month-old control Bax+/+; Prnp+/+ (E) and Bax−/−;Ngsk Prnp0/0 
(A–D, F) mice. Ultrastructural autophagic stages from phagophores to autolysosomes. A. Phagophore (*) and 
double-membraned autophagosome (arrowhead). B. Sequestration of two mitochondria in an autophagosome 
(arrowhead). Go, Golgi dichtyosome. C. Fusion of an autophagosome (arrowhead) with a lysosome (*). Ly, 
lysosomes. D. Autolysosomes (*). A–D. Scale bars = 500 nm. E. The somato-dendritic cytoplasm of this control 
Bax+/+; Prnp+/+ PC contains a few lysosomes and lipofuchsin bodies (arrowheads). N, nucleus; n, nucleolus. 
F. Autophagic PC with numerous autophagic organelles (arrowheads) accumulating in the neuroplasm. ML, 
molecular layer. IGL, internal granular layer. E, F. Arrows show PC axon. Scale bars = 2 μm.
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autophagy-inducing agents increased cellular clearance of PrPTSE [149–151], 
blocking the fusion of autophagosomes with lysosomes allowed visualization of 
PrPTSE in the autophagosomes suggesting that degradation of endosomal PrPTSE is 
by autophagy [134]. However, saturation of the autolysosomal degradation pro-
cess can release PrPTSE aggregates and degradation enzymes into the neuroplasm 
contributing to autophagy upregulation and neuronal death [134]. Nevertheless, 
although autophagy-inducing agents delayed disease onset and PrPTSE accumula-
tion in the CNS of mice [152], survival time was not modified [153]. Along this line, 
neither autophagy-inducing nor -inhibiting treatments altered the time course or 
amplitude of prion-induced neuronal death, strongly suggesting that autophagy 
in protein misfolding diseases is a secondary mechanism in the neurodegenerative 
process [141, 154].
3. Neuronal death in prion protein-deficient mice
3.1 Impaired autophagy in Zrch-1 prion protein-deficient mice
With the exception of the Prnp-knockout models in which ectopic expression 
of Doppel (Dpl) in the CNS leads to PC death, most other Prnp-knockout mouse 
models do not show gross abnormalities indicating that PrPc may be dispensable for 
embryonic development and adulthood. Nevertheless, PrP-deficient mice exhibit 
an increased predilection for seizures, motor and cognitive disabilities, reduced 
synaptic inhibition, and long term potentiation in the hippocampus. Also, altered 
development of the granule cell layer, dysregulation of the cerebellar network and 
age-dependent spongiform changes with reactive astrogliosis have been observed 
[155, 156]. In cultures of PrP-deficient hippocampal neurons, autophagy is upregu-
lated in the absence of serum or by hydrogen peroxide-induced oxidative stress 
[148, 157] suggesting that suppression of the protective effects of PrPc could impair 
the autophagic flux in PrP-deficient neurons in vivo. Indeed, ultrastructural exami-
nation of hippocampus and cerebral cortex of ZH-I Prnp0/0 mice revealed an accu-
mulation of autophagosomes containing incompletely digested material increasing 
from 3 to 12 months of age [158]. In addition, an ultrastructural examination of PCs 
in the cerebellum of ZH-I Prnp0/0 mice revealed significant autophagic accumula-
tion in the somato-dendritic compartment of these neurons from 6 to 14.5 months 
of age (Figure 11). Since autophagic cell death is known to induce neurodegenera-
tion [136, 159, 160], these signs of autophagy blockade could reflect a sustained, 
progressive autophagic neuronal loss in the CNS of the ZH-I Prnp0/0 mice.
3.2 Neuronal loss in Dpl-expressing Ngsk prion protein-deficient mice
Nagasaki (Ngsk) PrP-deficient mice which have a deletion of the entire Prnp 
gene [161–163] develop progressive cerebellar ataxia, which was later discovered to 
result from the absence of a splice acceptor site in exon 3 of Prnp [164]. This leads 
to the aberrant overexpression of the Prnd gene encoding the PrPc paralogue Dpl 
[165, 166] that causes selective degeneration of cerebellar PCs. Notably, the reintro-
duction of Prnp in mice overexpressing Prnd in the brain rescued the phenotype, 
suggesting a functional link between the two proteins [167]. Dpl has been shown 
to have intrinsic neurotoxic properties in cerebellar neurons [168] and has been 
proposed to interfere with PrPc and affect cell survival [100]. According to this 
hypothesis, PrPc and Dpl bind a common ligand LPrP, where PrPc binding induces a 
cell survival signal while Dpl binding activates a death signaling cascade. In PrPc-
deficient Prnp-knockout mice that do not express Dpl, the existence of a protein 
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Figure 11. 
Autophagy in ZH-I Prnp0/0 PCs. A. Mitophagy in the PC neuroplasm of a 4.5 months-old ZH-I Prnp0/0 mouse. 
Arrowhead shows the double membrane of an autophagic vacuole sequestrating a mitochondrion (m). Scale 
bar = 500 nm. B, C. 12 months-old ZH-I Prnp0/0 mice. PC layer. B. Autophagic PC containing numerous 
autophagosomes and autolysosomes (arrowheads). Scale bar = 2 μm. C. PC layer. Degenerating PC axons 
containing autophagosomes and lysosomes (*). Scale bar =500 nm.
π has been proposed to induce a cell survival signal when bound to LPrP [169]. 
For the moment, LPrP and π remain to be identified, as well as the neuronal death 
pathways involved in Dpl-induced PC loss.
Because Dpl neurotoxicity depends on PrPc-deficiency in PCs, investigating 
the underlying neurotoxic mechanism may provide important insight into the 
neuroprotective function of PrPc. The resistance of the PC population to neuro-
toxicity increased in the cerebellum of Ngsk mice, which were either deficient 
for the pro-apoptotic factor Bax [121] or over-express the anti-apoptotic factor 
Bcl-2 [170]. Although this suggests that an intrinsic apoptotic process is involved 
in the death of the Ngsk Prnp0/0 PCs, a significant PC loss still occurred in both 
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(Bax−/−; Ngsk Prnp0/0) and (HuBcl-2; Ngsk Prnp0/0) double mutants. Thus, the 
Ngsk condition, i.e., Dpl neurotoxicity and PrP-deficiency, could activate BAX-
independent mechanisms in the Ngsk Prnp0/0 PCs. These neurons exhibited 
robust autophagy well before significant neuronal death in the cerebellar cortex 
of the Ngsk Prnp0/0 mice [135, 171] suggesting that either “reactive” autophagy is 
initially induced as a neuroprotective response to Dpl neurotoxicity or impaired 
autophagy results from PrP-deficiency as in ZH-I Prnp0/0 mice (see above and 
[158]). Indeed, the increased expression of the autophagic markers SCRG1, 
LC3-II, and P62 proteins without any changes in mRNA levels, indicates that the 
ultimate steps of autophagic degradation are impaired in Ngsk Prnp0/0 PCs [135]. 
Probably due to this impairment of autophagic proteolysis, LC3-II-, and Lamp-1-
labeled autophagosomes and autolysosomes [172] accumulate in the Ngsk Prnp0/0 
PCs. How apoptosis and autophagy are involved in Ngsk Prnp0/0 PC death remains 
to be determined.
To further investigate the role of autophagy in the death of Ngsk Prnp0/0 PCs, 
a quantitative analysis of autophagic PCs was performed at the ultrastructural 
level in the cerebellum of Ngsk Prnp0/0, Bax−/−; Ngsk Prnp0/0, ZCH-I Prnp0/0 
and control Bax+/+;Prnp+/+ mice (Figure 12). At 4.5 months of age, equivalent 
amounts of autophagic somato-dendritic compartments and axons of PCs were 
found in the cerebella of Ngsk Prnp0/0 and Bax−/−; Ngsk Prnp0/0 mutants and 
were significantly more than those in ZCH-I Prnp0/0 and control Bax+/+;Prnp+/+ 
cerebella. Interestingly, the amounts of autophagic axons and somato-dendritic 
compartments of PCs in the ZCH-I Prnp0/0 and control Bax+/+;Prnp+/+ cerebella 
were not different. These data suggest that while autophagy induction is already 
visible in PCs with the Ngsk condition, it is not induced in control Bax+/+;Prnp+/+ 
PCs, nor in the absence of PrPc in the ZCH-I Prnp0/0 PCs. Thus, autophagy seems 
to be induced by Dpl neurotoxicity in the Ngsk condition whether BAX is present 
or not; whereas PrP-deficiency alone has no autophagy-inducing effect at this age 
(Figure 13).
At 6.5–7 months of age, the amount of autophagic somato-dendritic compart-
ments and axons of PC were significantly decreased in Bax−/−; Ngsk Prnp0/0 
cerebella compared with Ngsk Prnp0/0 cerebella. Consequently, the amount of 
autophagic PC profiles in the Bax−/−; Ngsk Prnp0/0 and ZH-I Prnp0/0 cerebella was 
equivalent, yet more than in the control Bax+/+;Prnp+/+ cerebella. Furthermore, 
autophagic PC somato-dendritic compartments and axons did not change from 4.5 
to 6.5–7 months of age in the Bax−/−; Ngsk Prnp0/0, whereas many more PCs were 
autophagic in the 6.5–7 month-old compared to the 4.5 month-old Ngsk Prnp0/0 cer-
ebella. This increase was also observed in ZH-I Prnp0/0 cerebella, while no autopha-
gic PCs were found in 6.5–7 month-old control Bax+/+;Prnp+/+ cerebella (Figure 13).
This suggests that BAX-deficiency modulates autophagy in Ngsk Prnp0/0 PCs 
after 4.5 months of age. Autophagy in the ZH-I Prnp0/0 PCs had increased to the 
same level as observed in the Bax−/−;Ngsk Prnp0/0 cerebella. Thus, the persistent 
autophagy in the PCs of the Bax−/−;Ngsk Prnp0/0 double mutants is likely related to 
PrP-deficiency. Also, autophagy- and Bax-dependent apoptosis are likely to occur in 
the same PCs that are rescued by Bax deletion.
At 12 months of age, the amount of autophagic somato-dendritic compart-
ments and axons of PCs in Bax−/−;Ngsk Prnp0/0 cerebella was equivalent to that 
found in 4.5 month-old cerebella suggesting that autophagy remains stable in this 
PC population, at a level similar to that maintained in the ZH-I Prnp0/0, and this 
likely results from PrP-deficiency. Indeed, many more autophagic PC somato-
dendritic compartments and axons were observed in ZH-I Prnp0/0 cerebella than 
in the cerebella of 12 month-old control Bax+/+;Prnp+/+ mice which did not contain 
autophagic PCs. However, the autophagic PC somato-dendritic compartments were 
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Figure 12. 
Quantitative analysis of autophagy in PCs of control Bax+/+;Prnp+/+ and PrP-deficient Bax+/+;Ngsk Prnp0/0, 
Bax−/−;Ngsk Prnp0/0 and ZH-I Prnp0/0 mutant mice. Autophagic somato-dendritic and axonal profiles 
were counted in 200 PCs in transverse cerebellar sections (50 PCs per hemisphere and hemivermis) from 
each mouse at 4.5, 6.5–7 and 12 months of age (n = 3 mice/age/genotype). PC soma, primary dendrite and 
axons were autophagic when containing three or more autophagic profiles (phagophore, autophagosome, 
autophagolysosome). Data are given as mean values ± standard deviation (SD). Statistical comparisons 
between ages and genotypes were performed using a two-tailed Student’s t test (Statistica). A. Mean 
percentages of autophagic PC somato-dendritic and axonal compartments. *, #, @, $, §: p < 0.01. B. Mean 
percentages of autophagic PC presynaptic boutons making symmetrical synapses on somato-dendritic profiles of 
deep cerebellar neurons. The PC presynaptic boutons were autophagic when containing at least one autophagic 
organelle. Autophagic PC presynaptic boutons were counted in 300 presynaptic boutons selected randomly in 
either left or right fastigial, interposed and dentate nuclei (100 boutons/nucleus) in three 12 month-old mice 
of each genotype. Statistical comparisons between genotypes were performed using a two-tailed Student’s t test 
(Statistica) and given as mean values ± standard deviation (SD). *, p < 0.01.
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still more in Ngsk Prnp0/0 cerebella (16.36 ± 7.9) compared with Bax−/−;Ngsk Prnp0/0 
(5.08 ± 5) cerebella, and there was a significant increase from 6.5–7 (14.38 ± 7.8) to 
12 months of age. The increased amount of autophagic PC axons in Bax−/−;Ngsk 
Prnp0/0 cerebella was stable during this same period (3.9 ± 5.6 at 6.5–7 months; 
5.08 ± 5.1 at 12 months), suggesting that the initiation of axonal autophagy peaks at 
6.5–7 months of age (Figure 12) [135, 171, 173–176]. In agreement, an examination 
of autophagy in the presynaptic terminals of PCs impinging on the somato-dendritic 
compartments of the deep nuclear neurons in the fastigial, interposed and dentate 
Figure 13. 
Autophagy in PCs of 7 (A, B) and 12 (C, D) month-old Bax−/−;Ngsk Prnp0/0 mice. A. PC-like somato-
dendritic profile containing numerous autophagic vacuoles and autolysosomes (arrowheads) in the PC layer. 
B. Autolysosomes (arrowheads) in a dystrophic PC-like, myelinated axonal profile in the internal granular 
layer. C. Autophagic vacuoles and autolysosomes in a PC-like somato-dendritic profile. D. Autophagic PC-like 
myelinated axon (*). Scale bars = 2 μm.
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Figure 14. 
Autophagy in the deep cerebellar nuclei of 13 month-old Ngsk (A, C–F) and 10 month-old ZH-I (B) Prnp0/0 
mice. A–E. PC presynaptic boutons establishing symmetrical synapses (arrowheads) with somato-dendritic 
profiles of deep cerebellar neurons (DCN) and containing different stages of double-membrane wraps 
sequestrating neuroplasm (* in A, B, D, E) and mitochondria (m in C, F). F. Myelinated PC-like axon with 
mitophagic profiles. Scale bars = 500 nm.
deep cerebellar nuclei, revealed a significantly greater amount of autophagic 
PC presynaptic boutons in the deep nuclei of all mutants compared to control 
Bax+/+;Prnp+/+ mice (Figure 14).
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The absence of BAX not only protected some PCs from neurotoxicity in the 
cerebellum of the Ngsk Prnp0/0 mice [121], but also decreased the number of 
autophagic neurons suggesting that the PCs rescued by Bax deficiency do not 
display activated autophagy, whereas the autophagic PCs in the Bax−/−;Ngsk Prnp0/0 
cerebellum are likely to result from PrP-deficiency as in the ZH-I Prnp0/0 cerebel-
lum. Nevertheless, the persistent loss of Bax−/−;Ngsk Prnp0/0 PCs could result 
from an increased sensitivity of these PCs to the Ngsk condition compared to ZH-I 
Prnp0/0 PCs.
The complex pattern of neuronal death observed in neurodegenerative 
diseases is believed to involve an extensive interplay between the major cell 
death pathways [177, 178]. This is likely the case in prion-infected, as well as 
PrP-deficient neurons such as PCs. We further investigated PC death in Ngsk 
Prnp0/0 and ZH-I Prnp0/0 COCS by measuring PC survival and development using 
morphometric methods [179] in COCS from these PrP-deficient mice. Similar 
timing and amplitude of PC growth impairment and death were observed in all 
PrP-deficient genotypes. Indeed, PC surface, perimeter, and dendritic extension 
increased between 7 and 21 DIV in the wild-type COCS, while no significant 
variation of surface and perimeter could be measured in the PrP-deficient mutant 
COCS during this period (Figure 15). Similarly, wild-type and PrP-deficient PCs 
displayed equivalent maximal dendritic extension after 7 days ex vivo, but wild-
type PCs continued to increase their maximal dendritic length until 21 DIV, while 
the dendrites of PrP-deficient PCs did not grow during this period [14, 180]. 
Thus, PrP-deficient PCs exhibit a similar developmental deficit which seems to be 
independent of Dpl expression in COCS.
The neurotoxic effects of PrP-deficiency were quantitatively analyzed by 
counting PCs at 3, 5, 7, 12, and 21 days in COCS from wild-type, Ngsk Prnp+/0, 
Ngsk Prnp0/0, and ZH-I Prnp0/0. Whereas, wild-type PCs’ numbers remained 
stable during the whole period, severe PC loss (68–69%) had occurred at 7 DIV 
and slightly increased up to 21 DIV in all PrP-deficient mutant COCS. PC loss 
displayed similar kinetics and amplitude in Ngsk Prnp+/0, Ngsk Prnp0/0, and ZH-I 
Prnp0/0 COCS suggesting that despite detectable levels of 15–20 kDa glycosylated 
form of Dpl in the Ngsk Prnp0/0 COCS (Figure 16), it may be not implicated in PC 
death in ex vivo cultures.
Furthermore, at the ultrastructural level, whereas autophagic organelles were rare 
in wild-type PCs after 7 and 12 DIV, Ngsk Prnp0/0 PCs contained numerous autopha-
gosomes and autophagolysosomes at different maturation stages (Figure 17). During 
the period of PC death in the Prnp0/0 COCS (i.e., 3, 5, and 7 DIV) Western blotting 
of apoptotic and autophagic markers revealed a 4- to 5-fold increase in markers of 
autophagosomal formation such as LC3B-II (at 5 DIV), p62, and beclin-1 (at 3 and 5 
DIV) in the ZH-I and Ngsk Prnp0/0 COCS and the lysosomal receptor LAMP-1 in the 
Ngsk Prnp0/0 COCS at 7 DIV (Figure 18). Increased amounts of activated caspase-3 
indicated the apoptosis in protein extracts of COCS from both Prnp0/0 genotypes as 
early as 3DIV [14].
This morphometric and quantitative analysis of COCS suggests that PrP-
deficiency, rather than Dpl neurotoxicity, is responsible for the neuronal growth 
deficit and loss ex vivo. Indeed, the neurotoxic properties of Dpl did not seem to 
contribute to Ngsk PC loss in the COCS, whereas Dpl-induced PC loss is detectable 
in 6-month-old Ngsk Prnp0/0 mice. A possible explanation for this difference is that 
COCS are not mature enough to model 6-month-old cerebellar tissue. Nevertheless, 
in Ngsk Prnp0/0 and ZH-I Prnp0/0 COCs, activation of autophagy and apoptosis is 
contemporaneous with the atrophy and death of PCs during the first week of cul-
ture suggesting that PrP-deficiency is solely responsible for neuronal death in this 
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ex vivo system and that PrPc is neuroprotective for cerebellar PCs. As ZH-I Prnp0/0 
PCs survive in vivo, PC death in ZH-I Prnp0/0 and Ngsk Prnp0/0 COCS could result 
from a noxious exacerbation of PrP-deficiency by ex vivo conditions.
Figure 15. 
PC growth deficits and loss in PrP-deficient COCS. A, B. PC area (A) and perimeter (B) of WT PCs 
increased from DIV7 to DIV21, whereas both dimensions in Ngsk Prnp+/0, Ngsk Prnp0/0 and ZH-I Prnp0/0 PCs 
did not change during the same period. A. At DIV7, WT PC area was larger than area of PrP-deficient PCs. 
C. While the longest dendrite of WT PCs had significantly grown from DIV7 to DIV21, the longest dendrite 
of PrP-deficient PCs displayed similar growth impairment suggesting that in both Ngsk and ZH-I conditions, 
PrP-deficiency is responsible for PC growth deficits. D–F. PC loss occurred progressively during the DIV7-DIV21 
period in WT COCS (40% at DIV21) while similar loss of PrP-deficient PCs had occurred in the Ngsk Prnp+/0, 
Ngsk Prnp0/0 (40%) and ZH-I Prnp0/0 (55%) COCS as early as DIV7. E. The Ngsk Prnp0/0 COCS had lost many 
more PCs than the WT COCS over the DIV3-DIV7 period indicating a neurotoxic effect during this period that 
is attributable to PrP-deficiency since the Ngsk and the ZH-I conditions induced similar neuronal loss at DIV7.
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Figure 16. 
Western blot of Dpl in Ngsk Prnp0/0 DIV7 COCS and 12 month-old mouse cerebellum. Dpl was detected in a 
Ngsk Prnp0/0 COCS at DIV7 and in situ in the cerebellar extract from a 12 month-old Ngsk Prnp0/0 mouse but 
not in the cerebellum of a wild-type (WT) mouse. Dpl migrates at 15–20 kDa after deglycosylation by peptide 
N-glucosidase (PNGase).
Figure 17. 
Autophagy in Ngsk Prnp0/0 PCs ex vivo. A. PC cytoplasm in a 12 DIV WT COCS. m, mitochondrion; l, 
lysosome. Scale bar = 500 nm. B–D. Autophagic PC cytoplasm in 7 DIV Ngsk Prnp0/0 COCSs. Asterisks 
indicate nascent autophagic vacuoles in B and different maturation stages of autophagolysosomes in C and D. 
n, nucleus. Scale bar = 2 μm.
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4. Conclusion
Although the contribution of apoptosis to prion-induced death of central neurons 
including cerebellar ones is strongly supported, our studies of scrapie-infected PCs 
show that although caspase-3 is activated, the pro-apoptotic BAX/BCL-2-dependent 
mitochondrial pathway is not involved in the prion-induced death of these neurons. 
This is also the case for BSE-induced death of hippocampal and thalamic neurons [119], 
suggesting that prions exert neurotoxicity through BAX-independent activation of 
caspase-3. Ultrastructural evidence of ER stress and robust autophagy in the scrapie-
infected cerebellar neurons both in vivo and ex vivo implicate them in these BAX-
independent neurotoxic mechanisms. Furthermore, the autophagic blockade resulting 
from prion protein-deficiency in ZH-I and Ngsk Prnp0/0 mice may contribute to neu-
ronal death in infectious prion-diseased cerebellar neurons. In Ngsk Prnp0/0 cerebellar 
neurons, Dpl neurotoxicity and PrP-deficiency contribute to neuronal death probably 
through an interplay between autophagic blockade and BAX-dependent apoptosis.
Figure 18. 
Western blot of autophagic markers p62, beclin-1 and LAMP-1. A. p62 and B. Beclin-1. The markers were 
weakly expressed in WT COCS, but increased in DIV3 and DIV5 COCS from PrP-deficient mice. C, D. 
LAMP-1 did not vary in WT and ZH-1 COCS from DIV3 to DIV7, but increased in DIV7 Ngsk Prnp0/0 COCS 
indicating increased lysosomal activity (p < 0.05; n = 3 mice/genotype and DIV).
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